European Commission (EC)
341 articles about European Commission (EC)
-
European Commission (EC) Grants Marketing Authorization For Gilead’s Once-Daily Truvada® For Reducing The Risk Of Sexually Acquired HIV-1
8/22/2016
-
European Commission (EC) Grants Marketing Authorization For Teva’s CINQAERO (Reslizumab)
8/18/2016
-
Merck & Co.’s KEYTRUDA (Pembrolizumab) Approved By The European Commission (EC) For Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1
8/3/2016
-
European Commission (EC) Grants Marketing Authorization For Merck & Co.’s ZEPATIER (Elbasvir/Grazoprevir) For The Treatment Of Chronic Hepatitis C Infection
7/29/2016
-
Celgene Release: REVLIMID (Lenalidomide) Approved By The European Commission (EC) For The Treatment Of Relapsed/Refractory Patients With Mantle Cell Lymphoma
7/15/2016
-
European Commission (EC) Grants Marketing Authorization For Gilead’s Epclusa (Sofosbuvir/Velpatasvir) For The Treatment Of All Genotypes Of Chronic Hepatitis C
7/8/2016
-
Takeda Receives European Commission (EC) Approval Of ADCETRIS (Brentuximab Vedotin) For Consolidation Treatment In Post-Transplant Hodgkin Lymphoma
7/6/2016
-
Seattle Genetics Announces European Commission (EC) Approval Of ADCETRIS (Brentuximab Vedotin) As Consolidation Treatment In Post-Transplant Hodgkin Lymphoma
7/6/2016
-
European Commission (EC) Approves Extended Indication For Amgen's Kyprolis (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients
7/5/2016
-
Bial Release: European Commission (EC) Approves ONGENTYS (Opicapone) – A Novel Treatment For Parkinson's Disease Patients With Motor Fluctuations
7/5/2016
-
European Commission (EC) Grants Marketing Authorization For Gilead’s Single Tablet Regimen Odefsey (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) For The Treatment Of HIV
6/23/2016
-
Alexion Release: European Commission (EC) Grants Orphan Drug Designation To ALXN1210 For The Treatment Of Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
6/2/2016
-
Janssen-Cilag International NV Release: European Commission (EC) Approves TREVICTA (Paliperidone Palmitate A 3-Monthly Injection), For Maintenance Treatment Of Schizophrenia
5/31/2016
-
AbbVie Release: European Commission (EC) Approves IMBRUVICA (Ibrutinib) For First-Line Treatment Of Patients With Chronic Lymphocytic Leukemia
5/31/2016
-
European Commission (EC) Approves the First and Only Immuno-Oncology Combination, Bristol-Myers Squibb’s Opdivo (Nivolumab) + Yervoy (Ipilimumab) Regimen, for Treatment of Advanced Melanoma
5/11/2016
-
European Commission (EC) Approves IDELVION --CSL Behring's Novel Hemophilia B Treatment With Up To 14-Day Dosing Intervals
5/11/2016
-
European Commission (EC) Grants Marketing Authorization For Gilead’s Fixed-Dose Combination Descovy (Emtricitabine, Tenofovir Alafenamide) For Treatment Of HIV
4/25/2016
-
European Commission (EC) Approves Expanded Use Of Bristol-Myers Squibb's Opdivo (Nivolumab) To Include Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
4/6/2016
-
European Commission (EC) Approves Bristol-Myers Squibb’s Opdivo (Nivolumab) For Previously Treated Advanced Renal Cell Carcinoma
4/6/2016
-
Takeda Release: European Commission (EC) Approves Label Variation For ADCETRIS (Brentuximab Vedotin) To Include Data On Retreatment Of Adult Patients With Relapsed Or Refractory Hodgkin Lymphoma And Systemic Anaplastic Large Cell Lymphoma (sALCL)
1/22/2016